Results 231 to 240 of about 429,935 (362)

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-study. [PDF]

open access: yesEur Heart J Open
Löffler F   +9 more
europepmc   +1 more source

Intracranial Brain Abscess in a Child with Cyanotic Congenital Heart Disease

open access: diamond, 2020
Maithili Prakash Joshi   +2 more
openalex   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Kidney Transplantation in Congenital Heart Disease Patients: What Are the Outcomes? [PDF]

open access: yesPediatr Transplant
O'Connor M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy